Compare Novo Nordisk A/S (NVO) vs Wolfspeed Inc (WOLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Wolfspeed Inc — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Wolfspeed Inc trades at $32.4 (market cap $1.53B). The key difference: Novo Nordisk A/S is far larger — about 144.1× Wolfspeed Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Wolfspeed Inc pays none. Which is the better fit depends on your goals.
| NVO | WOLF | |
|---|---|---|
Market Cap | $220.53B | $1.53B |
Sector | Health | Technology |
52-Week High | $71.70 | $73.68 |
52-Week Low | $35.29 | $1.19 |
Enterprise Value | $239.49B | $2.19B |
Dividend Yield | 3.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Wolfspeed Inc
Wolfspeed is the global leader in wide bandgap semiconductors, specializing in silicon carbide (SiC) and gallium nitride (GaN) materials and devices. It operates a vertically integrated model, controlling the entire process from raw material substrate production to advanced power modules, serving as a critical infrastructure provider for electric vehicles (EVs), renewable energy, and AI data centers.
Read more on WOLF →
